What's new

Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2025, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2025 to 10 April 2025

Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2025, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2025 to 10 April 2025

Apr 7, 2025 - 15:19
 0
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2025, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2025 to 10 April 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2025, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2025 to 10 April 2025
Read More

Tags:

Previous Article

Lexeo locks in pivotal trial plan as clinical data pump up prospects of cardiac ...

Next Article

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine...

Related Posts

Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Date of authorisation: 23/06/2017, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 28, 2025  0

Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Date of authorisation: 23/04/2007, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Thyrogen, thyrotropin alfa, Date of authorisation: 09/03/2000, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0